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Background: Recent studies suggest that CD44-ligation induces 
expression of vascular endothelial growth factor-C (VEGF-C) expres-
sion and that the induction of the cyclooxygenase (COX-2) is achieved 
through an upregulation of VEGF-C. It is postulated that individual 
role of CD44, VEGF-C and COX-2 involves cellular proliferation, 
angiogenesis and metastasis of cancer. We investigated the correlation 
of CD44, VEGF-C and COX-2 with clinicopathologic parameters and 
clinical outcomes in surgically resected NSCLC patients.
Methods: Using immunohistochemial staining, we analyzed the 
protein expressions of CD44s, CD44v6, COX-2 and VEGF-C on the 
tissue array specimens from 180 patients (adenocarcinoma (AC), n=90; 
squamous cell carcinoma (SCC), n=90) with completely resected 
NSCLC patients. 
Results: The median age was 64 (range, 19-88) and M:F ratio was 
141:39. According to pathologic stage by AJCC, stage I, II, III was 
101 (56.1%), 35 (19.4%) and 44 (24.4%). The expressions of CD44s, 
CD44v6, COX-2 and VEGF-C were observed in 65.7%, 37.6%, 40% 
and 60%, respectively. COX-2 overexpression was found in 51.1% of 
AC subtype and 28.9 % of SCC with statistically signiﬁcant difference. 
The expressions of both CD44s and CD44v6 were found to be more 
frequent in SCC with signiﬁcance, compared to those of AC (44.6% vs. 
26.2%, p<0.001; 6.6% vs. 34.1%, p<0.001). Overexpression of VEGF-
C was correlated with CD44 and COX-2 expression. It also had strong 
correlation with tumor size and differentiation (p=0.026, p=0.004). In 
the multivariate analysis, only lymph node metastasis was an indepen-
dent prognostic factor (HR 2.367, p<0.001), but none of these mol-
ecules showed statistical correlations. 
Conclusions: To be taken, the present study revealed that VEGF-C, 
correlated with CD44 and COX-2, was a strong predictive marker for 
tumor size in early stage of NSCLC.
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Objective: The purpose of this study was to identify risk factors for 
disease recurrence and unfavorable prognosis after surgical resection 
for stage IA non-small-cell lung cancer (NSCLC) in patients with 
tumor diameters of 20mm or less.
Materials and Methods: One hundred sixty-three patients who had 
pathologic stage IA NSCLC with tumor diameters ≤ 20mm and who 
had undergone a lobectomy with mediastinal lymph node dissection 
were retrospectively reviewed. The relationships between clinicopatho-
logical factors and clinical outcomes, including recurrence and sur-
vival, were then examined. The clinicopathological factors examined in 
this study were age, sex, smoking status, preoperative serum carcino-
embryonic antigen level, pathologic tumor size, histologic subtype, 
histologic grade, and visceral pleural invasion.
Results: Among the clinicopathological factors that were examined, 
the histologic grade of the carcinoma status was signiﬁcantly related 
to a high risk of recurrence when analyzed using univariate (P=0.01) 
and multivariate analyses (P=0.049). Regarding survival, patients with 
poorly differentiated carcinomas showed a signiﬁcantly unfavorable 
overall survival (OS) (P<0.001), disease-speciﬁc survival (P=0.003), 
and disease-free survival (DFS) (P=0.002), compared with patients 
with well/moderately differentiated carcinomas, according to univariate 
analyses (Figure). A Cox proportional hazards model indicated that a 
poorly differentiated carcinoma status was the only independent factor 
for an unfavorable OS (P=0.02), disease-speciﬁc survival (P=0.046) 
and DFS (P=0.04) (Table).
Conclusion: A lower histologic grade was the only risk factor for 
recurrence and an unfavorable prognosis for stage IA NSCLC patients 
with tumor diameters of 20mm or less.
